Intersect Capital’s Sanofi SNY Stock Holding History

Intersect Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-215	Closed	-$11K	–	327
2015 Q1	$11K	Buy	+215	New	+$10.3K	0.01%	320

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Intersect Capital's SNY Position: Q2 2015 in Review

Intersect Capital sold out of Sanofi (SNY) in Q2 2015, closing a stake of 215 shares — an estimated $11K sold.

Intersect Capital first reported a position in SNY in Q1 2015 and held it in 1 quarter. The position peaked at $11K in Q1 2015. 503 funds tracked by Wall St. Rank hold SNY as of Q2 2015.

Intersect Capital reported no remaining Sanofi position as of Q2 2015 after selling out during the quarter.
Intersect Capital sold 215 Sanofi shares in Q2 2015, an estimated $11K.
Intersect Capital first reported a position in Sanofi in Q1 2015 and held it in 1 quarter.
Intersect Capital's Sanofi position peaked at $11K in Q1 2015.
503 funds tracked by Wall St. Rank held Sanofi as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.